<?xml version="1.0" encoding="UTF-8"?>
<p>Although inflammation is a beneficial response that helps to protect the body from external pathogens, it is considered that excessive inflammatory responses should be controlled to prevent the development of chronic inflammation-associated diseases (
 <xref rid="b1-mmr-22-06-5219" ref-type="bibr">1</xref>,
 <xref rid="b2-mmr-22-06-5219" ref-type="bibr">2</xref>). The development of new anti-inflammatory agents is desirable due to the side effects and treatment failures associated with currently available anti-inflammatory drugs (
 <xref rid="b35-mmr-22-06-5219" ref-type="bibr">35</xref>). There is growing evidence that various plants and plant-derived compounds have therapeutic anti-inflammatory effects with few or no side effects (
 <xref rid="b35-mmr-22-06-5219" ref-type="bibr">35</xref>,
 <xref rid="b36-mmr-22-06-5219" ref-type="bibr">36</xref>). Thus, in the present study, the anti-inflammatory activity of HBL and HBB derived from honeyberry were evaluated and their potential molecular mechanisms of action were elucidated.
</p>
